← All stocks

RELMADA THERAPEUTICS, INC.

RLMD Net buying
CIK 0001553643 #3112 in the set updated 17 Sep 2026
Bought (1 mo)
$1.67M
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$1.67M
+$1.67M against sales at will

By person

5 insiders · 4 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Shenouda Maged
Chief Financial Officer
$843.99K (2)
+$843.99K
1,000,000
$4.10M
+1,032%
TRAVERSA SERGIO
Chief Executive Officer
$828.00K (2)
+$828.00K
1,500,000
$6.15M
+290.6%
Kelly Paul Edward
COO
502,295
$2.06M
+136.6%
Ence Chuck
CA and CO
403,931
$1.66M
+936.5%
CASAMENTO CHARLES J
Director
0
$0.00
−100.0%

No percentages here. This company's share count has moved by a factor of 3.5 over the window, from 30,174,202 to 106,669,846 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
TRAVERSA SERGIO
10 Sep 2026
Chief Executive Officer
Buy
100,000
$4.10
$410.00K
Shenouda Maged
10 Sep 2026
Chief Financial Officer
Buy
79,800
$4.25
$339.15K
TRAVERSA SERGIO
9 Sep 2026
Chief Executive Officer
Buy
100,000
$4.18
$418.00K
Shenouda Maged
9 Sep 2026
Chief Financial Officer
Buy
120,200
$4.20
$504.84K

What was left out

Form 4 filings counted 2
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 6 Oct 2017